Haemorrhoidal Disease
3
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Aesculus Hippocastanum And Interventions
Research Leaders
12 sponsors active, led by Fundação Educacional Serra dos Órgãos
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of PROCTOeze® PLUS
Randomized Study of Oral Aesculus Hippocastanum and Combinations in Hemorrhoidal Disease After 60 Days of Treatment
Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy
Research Network
Common Treatments
- Aesculus Hippocastanum And Interventions1
- Hydrophilic Emulsion For The Relief Of Haemorroidal Symptoms1
- Mesoglycan1
Active Sponsors
- Fundação Educacional Serra dos Órgãos1
- Alessandro Sturiale1
- Giuseppe Sammarco1
- Universidade Federal do Rio de Janeiro1
- Universidade Federal Fluminense1
Top Investigators
CMI Dr Sisu Lucia Cristina
Fundação Educacional Serra dos Órgãos
Related Conditions
- Postoperative Pain1
- Thrombosis1